Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2008, Article ID 931532, 7 pages
http://dx.doi.org/10.1155/2008/931532
Clinical Study

Chemotherapy Administration during Pelvic Radiation for Cervical Cancer Patients Aged ≥ 55 Years in the SEER-Medicare Population

1Department of Radiation Oncology, Case Comprehensive Cancer Center and University Hospitals of Cleveland Case Medical Center, Cleveland, OH 44106, USA
2Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Case Comprehensive Cancer Center and University Hospitals of Cleveland Case Medical Center, Cleveland, OH 44106, USA
3Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cleveland Clinic, Cleveland, OH 44197, USA

Received 2 June 2008; Accepted 31 July 2008

Academic Editor: Charles F. Levenback

Copyright © 2008 Charles Kunos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Waggoner, “Cervical cancer,” The Lancet, vol. 361, no. 9376, pp. 2217–2225, 2003. View at Publisher · View at Google Scholar
  2. C. W. Whitney, W. Sause, B. N. Bundy et al., “Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and southwest Oncology Group study,” Journal of Clinical Oncology, vol. 17, no. 5, pp. 1339–1348, 1999. View at Google Scholar
  3. P. G. Rose, B. N. Bundy, E. B. Watkins et al., “Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer,” The New England Journal of Medicine, vol. 340, no. 15, pp. 1144–1153, 1999. View at Publisher · View at Google Scholar
  4. P. J. Eifel, K. Winter, M. Morris et al., “Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01,” Journal of Clinical Oncology, vol. 22, no. 5, pp. 872–880, 2004. View at Publisher · View at Google Scholar
  5. C. McNeil, “New standard of care for cervical cancer sets stage for next questions,” Journal of the National Cancer Institute, vol. 91, no. 6, pp. 500–501, 1999. View at Publisher · View at Google Scholar
  6. J. Warren, C. Klabunde, D. Schrag, P. Bach, and G. Riley, “Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population,” Medical Care, vol. 40, supplement 8, pp. IV3–IV18, 2002. View at Google Scholar
  7. J. L. Warren, L. C. Harlan, A. Fahey et al., “Utility of the SEER-Medicare Data to identify chemotherapy use,” Medical Care, vol. 40, supplement 8, pp. IV55–IV61, 2002. View at Google Scholar
  8. National Cancer Institute, Cancer Statistics Branch, United States Surveillance, Epidemiology, and End Results (SEER) Public-Use Data (1973–1999), Vol. 2007, 2007.
  9. National Cancer Institute, Cancer Statistics Branch, United States Surveillance, Epidemiology, and End Results (SEER) Medicare Linked Database (1973–2002), Vol. 2007, 2007.
  10. Centers for Medicare and Medicaid Services and United States Department of Health and Human Services Healthcare Common Procedure Coding System, 2007.
  11. M. Charlson, P. Pompei, K. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Publisher · View at Google Scholar
  12. C. Klabunde, A. Potosky, J. Legler, and J. Warren, “Development of a comorbidity index using physician claims data,” Journal of Clinical Epidemiology, vol. 53, no. 12, pp. 1258–1267, 2000. View at Publisher · View at Google Scholar
  13. National Cancer Institute, Cancer Statistics Branch, United States Surveillance, Epidemiology, and End Results (SEER) Medicare Linked Database (1973–2002), Calculation of comorbidity weights, Vol. 2007, 2007.
  14. C. Klabunde, J. Warren, and J. Legler, “Assessing comorbidity using claims data: an overview,” Medical Care, vol. 40, supplement 8, pp. 26–35, 2002. View at Publisher · View at Google Scholar
  15. F. B. Stehman, B. N. Bundy, P. J. DiSaia, H. M. Keys, J. E. Larson, and W. C. Fowler, “Carcinoma of the cervix treated with radiation therapy—I: a multi-variate analysis of prognostic variables in the gynecologic oncology Group,” Cancer, vol. 67, no. 11, pp. 2776–2785, 1991. View at Publisher · View at Google Scholar
  16. J. Wright, R. Gibb, S. Geevarghese et al., “Cervical carcinoma in the elderly. An analysis of patterns of care and outcome,” Cancer, vol. 103, no. 1, pp. 85–91, 2005. View at Publisher · View at Google Scholar
  17. P. J. Eifel, J. Moughan, B. Erickson, T. Iarocci, D. Grant, and J. Owen, “Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study,” International Journal of Radiation Oncology, Biology, Physics, vol. 60, no. 4, pp. 1144–1153, 2004. View at Google Scholar
  18. A. Coker, X. Du, S. Fang, and K. Eggleston, “Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts,” Gynecologic Oncology, vol. 102, no. 2, pp. 278–284, 2006. View at Publisher · View at Google Scholar
  19. United States Census Bureau, United States Census 2000 Demographic Profiles, Vol. 2008, 2008.
  20. D. A. Patel, J. A. Barnholtz-Sloan, M. K. Patel, J. M. Malone, P. J. Chuba, and K. Schwartz, “A population-based study of racial and thnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data,” Gynecologic Oncology, vol. 97, no. 2, pp. 550–558, 2005. View at Publisher · View at Google Scholar